226 related articles for article (PubMed ID: 14991920)
1. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
Dziadek S; Kunz H
Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
Dziadek S; Brocke C; Kunz H
Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
[TBL] [Abstract][Full Text] [Related]
3. Synthetic glycopeptides for the development of tumour-selective vaccines.
Kunz H
J Pept Sci; 2003 Sep; 9(9):563-73. PubMed ID: 14552419
[TBL] [Abstract][Full Text] [Related]
4. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
[TBL] [Abstract][Full Text] [Related]
5. Solution-phase synthesis with solid-state workup of an O-glycopeptide with a cluster of cancer-related T antigens.
Shao N; Guo Z
Org Lett; 2005 Aug; 7(16):3589-92. PubMed ID: 16048349
[TBL] [Abstract][Full Text] [Related]
6. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of tumor-associated glycopeptide antigens.
Brocke C; Kunz H
Bioorg Med Chem; 2002 Oct; 10(10):3085-112. PubMed ID: 12150854
[TBL] [Abstract][Full Text] [Related]
8. The (2-phenyl-2-trimethylsilyl)ethyl-(PTMSEL)-linker in the synthesis of glycopeptide partial structures of complex cell surface glycoproteins.
Wagner M; Dziadek S; Kunz H
Chemistry; 2003 Dec; 9(24):6018-30. PubMed ID: 14679514
[TBL] [Abstract][Full Text] [Related]
9. Synthetic glycopeptides for the development of cancer vaccines.
Liakatos A; Kunz H
Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
[TBL] [Abstract][Full Text] [Related]
10. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
11. Multiple column synthesis of a library of T-cell stimulating Tn-antigenic glycopeptide analogues for the molecular characterization of T-cell-glycan specificity.
Frische K; Meldal M; Werdelin O; Mouritsen S; Jensen T; Galli-Stampino L; Bock K
J Pept Sci; 1996; 2(4):212-22. PubMed ID: 9231328
[TBL] [Abstract][Full Text] [Related]
12. A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response.
Kaiser A; Gaidzik N; Westerlind U; Kowalczyk D; Hobel A; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2009; 48(41):7551-5. PubMed ID: 19685547
[No Abstract] [Full Text] [Related]
13. Formation of lactones from sialylated MUC1 glycopeptides.
Pudelko M; Lindgren A; Tengel T; Reis CA; Elofsson M; Kihlberg J
Org Biomol Chem; 2006 Feb; 4(4):713-20. PubMed ID: 16467946
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of tumor associated sialyl-T-glycopeptides and their immunogenicity.
Komba S; Werdelin O; Jensen T; Meldal M
J Pept Sci; 2000 Dec; 6(12):585-93. PubMed ID: 11192238
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective synthesis of sialylated tumor-associated glycosylamino acids.
Corcilius L; Payne RJ
Org Lett; 2013 Nov; 15(22):5794-7. PubMed ID: 24160308
[TBL] [Abstract][Full Text] [Related]
18. Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.
Cai H; Sun ZY; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2013 Feb; 19(6):1962-70. PubMed ID: 23280874
[TBL] [Abstract][Full Text] [Related]
19. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
Buskas T; Ingale S; Boons GJ
Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
[No Abstract] [Full Text] [Related]
20. Oligosaccharide-peptide ligation of glycosyl thiolates with dehydropeptides: synthesis of S-linked mucin-related glycopeptide conjugates.
Galonić DP; Van Der Donk WA; Gin DY
Chemistry; 2003 Dec; 9(24):5997-6006. PubMed ID: 14679512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
